Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Eurasian Journal of Medicine|August 11, 2024
Aquaporins: Potential Targets in Inflammatory DiseasesAyse Bozkurt, Hamza Halici, Muhammed Yayla
Journal of Receptor and Signal Transduction Research|January 4, 2025
Novel therapeutic approaches targeting 5-HT7 receptors outside the central nervous systemMelis Kilic, Zeynep Karakoy, Hamza Halici, et al.
Cardiovascular Toxicology|October 2, 2021
In Vivo and In Vitro Cardioprotective Effect of Gossypin Against Isoproterenol-Induced Myocardial Infarction InjuryIrfan Cinar, Muhammed Yayla, Taha Tavaci, et al.
The Journal of Pharmacy and Pharmacology|October 30, 2025
Effect of pigment epithelium-derived factor on prostaglandin E2 receptors (EP2/EP4) in glucocorticoid-induced osteoporosis in ratsZerrin Kutlu, Zekai Halici, Fatih Alper, et al.
The Protein Journal|February 7, 2025
The Effect of Inhaled Ozone Therapy in Two-Hit Rat Model of Lipopolysaccharides-Induced Acute Lung Injury and Bleomycin-Induced Pulmonary FibrosisMine Celik, Mehmet Koca, Zekai Halici, et al.
Brain Injury|April 27, 2024
Inflammation in cerebral ischemia reperfusion improved by avanafil via nod-like receptor protein-3 inflammasome: an experimental study in ratsHuseyin Bekmez, Mehmet Nuri Kocak, Taha Tavaci, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 13, 2026
Detorsion is not innocent: pirfenidone prevents contralateral ovarian damage following ovarian torsionHamza Halici, Zeynep Karakoy, Emir Enis Yurdgulu, et al.
Clinical and Experimental Pharmacology & Physiology|March 9, 2021
Neuroprotective effect of roflumilast under cerebral ischaemia/reperfusion injury in juvenile rats through NLRP-mediated inflammatory response inhibitionHalil Keskin, Filiz Keskin, Taha Tavaci, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|July 9, 2021
Early administration of milrinone ameliorates lung and kidney injury during sepsis in juvenile ratsHalil Keskin, Taha Tavaci, Hamza Halici, et al.
Lung|August 30, 2022
Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-κB-NLRP3 Inflammasome Signaling PathwayPelin Aydin, Zeynep Berna Aksakalli Magden, Sevgi Karabulut Uzuncakmak, et al.
Pageof 2